APO RESEARCH · REPORT
2,3-Bornanedione
2,3-Bornanedione is a carbonyl-containing chemical substance identified by its named structure.

Product & engineering
Understand the product.
The full named identity, positional or stereochemical form, assay basis, impurity profile and supplied form define 2,3-Bornanedione. Material qualification and downstream formulation acceptance are distinct requirements; report segmentation is not a supplier specification.
The commercial boundary
Use the selected edition’s stated product level, geography, years and measurement basis. Materials, components, finished systems and services are separate commercial boundaries unless that edition explicitly combines them.
Which supplied interfaces and acceptance criteria define 2,3-Bornanedione?
The full named identity, positional or stereochemical form, assay basis, impurity profile and supplied form define 2,3-Bornanedione. Material qualification and downstream formulation acceptance are distinct requirements; report segmentation is not a supplier specification.
Selected research
Market Analysis & Forecast
Global 2,3-Bornanedione Market Analysis and Forecast 2026-2032
Market perspective
The global 2,3-Bornanedione market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
2,3-Bornanedione's global sales reached XX (t) with a value of US$ XX Million, marking an change of XX% compared to the previous year. This performance has positioned Yuanshu Pharmaceutical Technology as the global sales leader, a title it has maintained for several consecutive years. Notably, Yuanshu Pharmaceutical Technology's performance in primary markets is also remarkable. In the Chinese market, sales were XX (t), a change of XX% from the previous year. In Europe, sales were XX (t), showing a year-on-year of XX%. In the US, sales were XX (t), a year-on-year change of XX%.
The major global manufacturers in the 2,3-Bornanedione market include Yuanshu Pharmaceutical Technology, Haihang Group, Warshel Chemical, Starsky International Holdings, Shiv Shakti Pharma Chem, Sarex and Resins and Allied Products, etc. In 2025, the top three vendors accounted for approximately % of the revenue.
Read the full market overview
In terms of production side, this report researches the 2,3-Bornanedione production, growth rate, market share by manufacturers and by region (region level and country level), from 2021 to 2026, and forecast to 2032.
In terms of consumption side, this report focuses on the sales of 2,3-Bornanedione by region (region level and country level), by Company, by Type and by Application. from 2021 to 2026 and forecast to 2032.
This report presents an overview of global market for 2,3-Bornanedione, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of 2,3-Bornanedione, also provides the consumption of main regions and countries. Of the upcoming market potential for 2,3-Bornanedione, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the 2,3-Bornanedione sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global 2,3-Bornanedione market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for 2,3-Bornanedione sales, projected growth trends, production technology, application and end-user industry.
2,3-Bornanedione Segment by Company
Yuanshu Pharmaceutical Technology
Haihang Group
Warshel Chemical
Starsky International Holdings
Shiv Shakti Pharma Chem
Sarex
Resins and Allied Products
2,3-Bornanedione Segment by Type
Purity ≥98%
Purity ≥99%
Others
2,3-Bornanedione Segment by Application
Dentistry
Electronics Industry
Others
2,3-Bornanedione Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 2,3-Bornanedione market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of 2,3-Bornanedione and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 2,3-Bornanedione.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: 2,3-Bornanedione production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 4: Sales (consumption), revenue of 2,3-Bornanedione in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 5: Detailed analysis of 2,3-Bornanedione manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, 2,3-Bornanedione sales, revenue, price, gross margin, and recent development, etc.
Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 11: China by type, by application, sales, and revenue for each segment.
Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 15: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity ≥98%
- Purity ≥99%
- Others
Applications
- Dentistry
- Electronics Industry
- Others
Companies covered
- Yuanshu Pharmaceutical Technology
- Haihang Group
- Warshel Chemical
- Starsky International Holdings
- Shiv Shakti Pharma Chem
- Sarex
- Resins and Allied Products
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 2,3-Bornanedione Market by Type
- 1.2.1 Global 2,3-Bornanedione Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Purity ≥98%
- 1.2.3 Purity ≥99%
- 1.2.4 Others
- 1.3 2,3-Bornanedione Market by Application
- 1.3.1 Global 2,3-Bornanedione Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Dentistry
- 1.3.3 Electronics Industry
- 1.3.4 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 2,3-Bornanedione Market Dynamics
- 2.1 2,3-Bornanedione Industry Trends
- 2.2 2,3-Bornanedione Industry Drivers
- 2.3 2,3-Bornanedione Industry Opportunities and Challenges
- 2.4 2,3-Bornanedione Industry Restraints
3 Global 2,3-Bornanedione Production Overview
- 3.1 Global 2,3-Bornanedione Production Capacity (2021-2032)
- 3.2 Global 2,3-Bornanedione Production by Region: 2021 VS 2025 VS 2032
- 3.3 Global 2,3-Bornanedione Production by Region
- 3.3.1 Global 2,3-Bornanedione Production by Region (2021-2026)
- 3.3.2 Global 2,3-Bornanedione Production by Region (2027-2032)
- 3.3.3 Global 2,3-Bornanedione Production Market Share by Region (2021-2032)
- 3.4 North America
- 3.5 Europe
- 3.6 China
- 3.7 Japan
4 Global Market Growth Prospects
- 4.1 Global 2,3-Bornanedione Revenue Estimates and Forecasts (2021-2032)
- 4.2 Global 2,3-Bornanedione Revenue by Region
- 4.2.1 Global 2,3-Bornanedione Revenue by Region: 2021 VS 2025 VS 2032
- 4.2.2 Global 2,3-Bornanedione Revenue by Region (2021-2026)
- 4.2.3 Global 2,3-Bornanedione Revenue by Region (2027-2032)
- 4.2.4 Global 2,3-Bornanedione Revenue Market Share by Region (2021-2032)
- 4.3 Global 2,3-Bornanedione Sales Estimates and Forecasts 2021-2032
- 4.4 Global 2,3-Bornanedione Sales by Region
- 4.4.1 Global 2,3-Bornanedione Sales by Region: 2021 VS 2025 VS 2032
- 4.4.2 Global 2,3-Bornanedione Sales by Region (2021-2026)
- 4.4.3 Global 2,3-Bornanedione Sales by Region (2027-2032)
- 4.4.4 Global 2,3-Bornanedione Sales Market Share by Region (2021-2032)
- 4.5 North America
- 4.6 Europe
- 4.7 China
- 4.8 Asia (Excluding China)
- 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
- 5.1 Global 2,3-Bornanedione Revenue by Manufacturers
- 5.1.1 Global 2,3-Bornanedione Revenue by Manufacturers (2021-2026)
- 5.1.2 Global 2,3-Bornanedione Revenue Market Share by Manufacturers (2021-2026)
- 5.1.3 Global 2,3-Bornanedione Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 5.2 Global 2,3-Bornanedione Sales by Manufacturers
- 5.2.1 Global 2,3-Bornanedione Sales by Manufacturers (2021-2026)
- 5.2.2 Global 2,3-Bornanedione Sales Market Share by Manufacturers (2021-2026)
- 5.2.3 Global 2,3-Bornanedione Manufacturers Sales Share Top 10 and Top 5 in 2025
- 5.3 Global 2,3-Bornanedione Sales Price by Manufacturers (2021-2026)
- 5.4 Global 2,3-Bornanedione Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 5.5 Global 2,3-Bornanedione Key Manufacturers Manufacturing Sites & Headquarters
- 5.6 Global 2,3-Bornanedione Manufacturers, Product Type & Application
- 5.7 Global 2,3-Bornanedione Manufacturers Commercialization Time
- 5.8 Market Competitive Analysis
- 5.8.1 Global 2,3-Bornanedione Market CR5 and HHI
- 5.8.2 2025 2,3-Bornanedione Tier 1, Tier 2, and Tier 3
6 2,3-Bornanedione Market by Type
- 6.1 Global 2,3-Bornanedione Revenue by Type
- 6.1.1 Global 2,3-Bornanedione Revenue by Type (2021-2032) & (US$ Million)
- 6.1.2 Global 2,3-Bornanedione Revenue Market Share by Type (2021-2032)
- 6.2 Global 2,3-Bornanedione Sales by Type
- 6.2.1 Global 2,3-Bornanedione Sales by Type (2021-2032) & (t)
- 6.2.2 Global 2,3-Bornanedione Sales Market Share by Type (2021-2032)
- 6.3 Global 2,3-Bornanedione Price by Type
7 2,3-Bornanedione Market by Application
- 7.1 Global 2,3-Bornanedione Revenue by Application
- 7.1.1 Global 2,3-Bornanedione Revenue by Application (2021-2032) & (US$ Million)
- 7.1.2 Global 2,3-Bornanedione Revenue Market Share by Application (2021-2032)
- 7.2 Global 2,3-Bornanedione Sales by Application
- 7.2.1 Global 2,3-Bornanedione Sales by Application (2021-2032) & (t)
- 7.2.2 Global 2,3-Bornanedione Sales Market Share by Application (2021-2032)
- 7.3 Global 2,3-Bornanedione Price by Application
8 Company Profiles
- 8.1 Yuanshu Pharmaceutical Technology
- 8.1.1 Yuanshu Pharmaceutical Technology Company Information
- 8.1.2 Yuanshu Pharmaceutical Technology Business Overview
- 8.1.3 Yuanshu Pharmaceutical Technology 2,3-Bornanedione Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.1.4 Yuanshu Pharmaceutical Technology 2,3-Bornanedione Product Portfolio
- 8.1.5 Yuanshu Pharmaceutical Technology Recent Developments
- 8.2 Haihang Group
- 8.2.1 Haihang Group Company Information
- 8.2.2 Haihang Group Business Overview
- 8.2.3 Haihang Group 2,3-Bornanedione Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.2.4 Haihang Group 2,3-Bornanedione Product Portfolio
- 8.2.5 Haihang Group Recent Developments
- 8.3 Warshel Chemical
- 8.3.1 Warshel Chemical Company Information
- 8.3.2 Warshel Chemical Business Overview
- 8.3.3 Warshel Chemical 2,3-Bornanedione Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.3.4 Warshel Chemical 2,3-Bornanedione Product Portfolio
- 8.3.5 Warshel Chemical Recent Developments
- 8.4 Starsky International Holdings
- 8.4.1 Starsky International Holdings Company Information
- 8.4.2 Starsky International Holdings Business Overview
- 8.4.3 Starsky International Holdings 2,3-Bornanedione Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.4.4 Starsky International Holdings 2,3-Bornanedione Product Portfolio
- 8.4.5 Starsky International Holdings Recent Developments
- 8.5 Shiv Shakti Pharma Chem
- 8.5.1 Shiv Shakti Pharma Chem Company Information
- 8.5.2 Shiv Shakti Pharma Chem Business Overview
- 8.5.3 Shiv Shakti Pharma Chem 2,3-Bornanedione Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.5.4 Shiv Shakti Pharma Chem 2,3-Bornanedione Product Portfolio
- 8.5.5 Shiv Shakti Pharma Chem Recent Developments
- 8.6 Sarex
- 8.6.1 Sarex Company Information
- 8.6.2 Sarex Business Overview
- 8.6.3 Sarex 2,3-Bornanedione Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.6.4 Sarex 2,3-Bornanedione Product Portfolio
- 8.6.5 Sarex Recent Developments
- 8.7 Resins and Allied Products
- 8.7.1 Resins and Allied Products Company Information
- 8.7.2 Resins and Allied Products Business Overview
- 8.7.3 Resins and Allied Products 2,3-Bornanedione Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.7.4 Resins and Allied Products 2,3-Bornanedione Product Portfolio
- 8.7.5 Resins and Allied Products Recent Developments
9 North America
- 9.1 North America 2,3-Bornanedione Market Size by Type
- 9.1.1 North America 2,3-Bornanedione Revenue by Type (2021-2032)
- 9.1.2 North America 2,3-Bornanedione Sales by Type (2021-2032)
- 9.1.3 North America 2,3-Bornanedione Price by Type (2021-2032)
- 9.2 North America 2,3-Bornanedione Market Size by Application
- 9.2.1 North America 2,3-Bornanedione Revenue by Application (2021-2032)
- 9.2.2 North America 2,3-Bornanedione Sales by Application (2021-2032)
- 9.2.3 North America 2,3-Bornanedione Price by Application (2021-2032)
- 9.3 North America 2,3-Bornanedione Market Size by Country
- 9.3.1 North America 2,3-Bornanedione Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 North America 2,3-Bornanedione Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 North America 2,3-Bornanedione Price by Country (2021-2032)
- 9.3.4 United States
- 9.3.5 Canada
- 9.3.6 Mexico
10 Europe
- 10.1 Europe 2,3-Bornanedione Market Size by Type
- 10.1.1 Europe 2,3-Bornanedione Revenue by Type (2021-2032)
- 10.1.2 Europe 2,3-Bornanedione Sales by Type (2021-2032)
- 10.1.3 Europe 2,3-Bornanedione Price by Type (2021-2032)
- 10.2 Europe 2,3-Bornanedione Market Size by Application
- 10.2.1 Europe 2,3-Bornanedione Revenue by Application (2021-2032)
- 10.2.2 Europe 2,3-Bornanedione Sales by Application (2021-2032)
- 10.2.3 Europe 2,3-Bornanedione Price by Application (2021-2032)
- 10.3 Europe 2,3-Bornanedione Market Size by Country
- 10.3.1 Europe 2,3-Bornanedione Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 10.3.2 Europe 2,3-Bornanedione Sales by Country (2021 VS 2025 VS 2032)
- 10.3.3 Europe 2,3-Bornanedione Price by Country (2021-2032)
- 10.3.4 Germany
- 10.3.5 France
- 10.3.6 U.K.
- 10.3.7 Italy
- 10.3.8 Russia
- 10.3.9 Spain
- 10.3.10 Netherlands
- 10.3.11 Switzerland
- 10.3.12 Sweden
11 China
- 11.1 China 2,3-Bornanedione Market Size by Type
- 11.1.1 China 2,3-Bornanedione Revenue by Type (2021-2032)
- 11.1.2 China 2,3-Bornanedione Sales by Type (2021-2032)
- 11.1.3 China 2,3-Bornanedione Price by Type (2021-2032)
- 11.2 China 2,3-Bornanedione Market Size by Application
- 11.2.1 China 2,3-Bornanedione Revenue by Application (2021-2032)
- 11.2.2 China 2,3-Bornanedione Sales by Application (2021-2032)
- 11.2.3 China 2,3-Bornanedione Price by Application (2021-2032)
12 Asia (Excluding China)
- 12.1 Asia 2,3-Bornanedione Market Size by Type
- 12.1.1 Asia 2,3-Bornanedione Revenue by Type (2021-2032)
- 12.1.2 Asia 2,3-Bornanedione Sales by Type (2021-2032)
- 12.1.3 Asia 2,3-Bornanedione Price by Type (2021-2032)
- 12.2 Asia 2,3-Bornanedione Market Size by Application
- 12.2.1 Asia 2,3-Bornanedione Revenue by Application (2021-2032)
- 12.2.2 Asia 2,3-Bornanedione Sales by Application (2021-2032)
- 12.2.3 Asia 2,3-Bornanedione Price by Application (2021-2032)
- 12.3 Asia 2,3-Bornanedione Market Size by Country
- 12.3.1 Asia 2,3-Bornanedione Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 Asia 2,3-Bornanedione Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 Asia 2,3-Bornanedione Price by Country (2021-2032)
- 12.3.4 Japan
- 12.3.5 South Korea
- 12.3.6 India
- 12.3.7 Australia
- 12.3.8 Taiwan
- 12.3.9 Southeast Asia
13 South America, Middle East and Africa
- 13.1 SAMEA 2,3-Bornanedione Market Size by Type
- 13.1.1 SAMEA 2,3-Bornanedione Revenue by Type (2021-2032)
- 13.1.2 SAMEA 2,3-Bornanedione Sales by Type (2021-2032)
- 13.1.3 SAMEA 2,3-Bornanedione Price by Type (2021-2032)
- 13.2 SAMEA 2,3-Bornanedione Market Size by Application
- 13.2.1 SAMEA 2,3-Bornanedione Revenue by Application (2021-2032)
- 13.2.2 SAMEA 2,3-Bornanedione Sales by Application (2021-2032)
- 13.2.3 SAMEA 2,3-Bornanedione Price by Application (2021-2032)
- 13.3 SAMEA 2,3-Bornanedione Market Size by Country
- 13.3.1 SAMEA 2,3-Bornanedione Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 13.3.2 SAMEA 2,3-Bornanedione Sales by Country (2021 VS 2025 VS 2032)
- 13.3.3 SAMEA 2,3-Bornanedione Price by Country (2021-2032)
- 13.3.4 Brazil
- 13.3.5 Argentina
- 13.3.6 Chile
- 13.3.7 Colombia
- 13.3.8 Peru
- 13.3.9 Saudi Arabia
- 13.3.10 Israel
- 13.3.11 UAE
- 13.3.12 Turkey
- 13.3.13 Iran
- 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
- 14.1 2,3-Bornanedione Value Chain Analysis
- 14.1.1 2,3-Bornanedione Key Raw Materials
- 14.1.2 Raw Materials Key Suppliers
- 14.1.3 Manufacturing Cost Structure
- 14.1.4 2,3-Bornanedione Production Mode & Process
- 14.2 2,3-Bornanedione Sales Channels Analysis
- 14.2.1 Direct Comparison with Distribution Share
- 14.2.2 2,3-Bornanedione Distributors
- 14.2.3 2,3-Bornanedione Customers
15 Concluding Insights
16 Appendix
- 16.1 Reasons for Doing This Study
- 16.2 Research Methodology
- 16.3 Research Process
- 16.4 Authors List of This Report
- 16.5 Data Source
- 16.5.1 Secondary Sources
- 16.5.2 Primary Sources
- 16.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst